Cargando…
A single stent strategy in patients with lifestyle limiting claudication: 3‐year results from the Durability II trial
OBJECTIVES: To evaluate longer‐term safety and efficacy of a single self‐expanding stent up to 20 cm in length in patients with atherosclerotic disease of the superficial femoral (SFA) and proximal popliteal arteries. BACKGROUND: Angioplasty and stenting are options for revascularization of symptoma...
Autores principales: | Rocha‐Singh, Krishna J., Bosiers, Marc, Schultz, Greg, Jaff, Michael R., Mehta, Manish, Matsumura, Jon S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024011/ https://www.ncbi.nlm.nih.gov/pubmed/25676568 http://dx.doi.org/10.1002/ccd.25895 |
Ejemplares similares
-
Paclitaxel exposure: Long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials
por: Schneider, Peter A., et al.
Publicado: (2020) -
Individual patient data meta‐analysis of patients treated with a heparin‐bonded Viabahn in the femoropopliteal artery for chronic limb‐threatening ischemia
por: Groot Jebbink, Erik, et al.
Publicado: (2022) -
Drug‐coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2‐year results of the MDT‐2113 SFA Japan randomized trial
por: Iida, Osamu, et al.
Publicado: (2019) -
Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
por: Schroë, Herman, et al.
Publicado: (2017) -
PERFORMANCE 1 study: Novel carotid stent system with integrated post‐dilation balloon and embolic protection device
por: Langhoff, Ralf, et al.
Publicado: (2022)